Veriheal

MARCH 20, 2023

Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. Smith cited results from clinical trials showing that MDMA holds promise in the treatment of PTSD. Connecticut Gov. Minnesota Rep.

Clinical Trials 98

Clinical Trials Therapy Decriminalization Treatment 98

Cannabis Law Report

OCTOBER 6, 2021

NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is pleased to announce that it has signed an agreement to begin scientific clinical trials globally. MIAMI & TORONTO–(BUSINESS WIRE)–Flora Growth Corp. About Flora Growth Corp.

Clinical Trials 40

Clinical Trials Research and Development Pharmaceutical Events 40

MMJ Recs

JULY 11, 2024

Medical marijuana is a potential treatment for insomnia, and it offers an alternative to traditional pharmaceuticals. Chronic insomnia often requires a more comprehensive treatment approach. It not only impacts mental and physical health but also diminishes quality of life by affecting concentration, mood, and overall productivity.

Sleep 111

Sleep Treatment Research and Development Therapy 111

Cannabis Law Report

AUGUST 10, 2022

Researchers will explore whether the psychoactive effects are necessary to relieve treatment-resistant depression in adults. It’s clear that alternative treatment options are necessary to combat depression and other mental illnesses, which is where companies developing psychedelic-based treatments like Optimi Health Corp.

Clinical Trials 52

Clinical Trials Research and Development Therapy Microdosing 52

Cannabis Law Report

JULY 13, 2022

Their position as therapeutic practitioners, as well as their work in conducting the kind of clinical trials necessary to advance regulatory outcomes for psychedelic medicines, make them ideal partners in alignment with Optimi’s strategic goals.”. VANCOUVER, British Columbia, July 13, 2022 (GLOBE NEWSWIRE) — Optimi Health Corp. (

Therapy 52

Therapy Clinical Trials Microdosing Research and Development 52

Cannabis Law Report

MAY 29, 2019

The research will focus on the optimisation of breeding and cultivating processes and the extraction of material to assess their efficacy of medical cannabis on prostate, melanoma and other cancer cells. All intellectual property from the trials will be owned by MGC, which is funding the research. Here’s the press release.

Cultivation 40

Cultivation Pharmaceutical Clinical Trials Extraction 40

Cannabis Law Report

JUNE 21, 2021

(OTC: EHVVF) adds Dr. Jeffrey Kamlet, an expert on cardiac safety in ibogaine treatment, as Chief Medical Officer. retains CRO Sante Cannabis to conduct clinical trials in psilocybin therapies. CSE: AREV) completes land survey and soil analysis for cultivation of mushrooms and moringa. Press Release. Press Release.

Clinical Trials 66

Clinical Trials Research and Development Therapy Pharmaceutical 66

Cannabis Law Report

JUNE 24, 2022

The leader of the New Jersey Senate filed a bill on Thursday that would legalize the possession, home cultivation and gifting of psilocybin mushrooms for adults 21 and older—with provisions that give adults even more freedoms for the psychedelic than are afforded under the state’s current marijuana laws. Marijuana Moment reports.

Clinical Trials 52

Clinical Trials Legalization Research and Development Therapy 52

SpeedWeed

MARCH 28, 2021

CANNABIS CULTURE – The results are now in after the first-ever legal clinical trial into the use of cannabis to treat PTSD, but did the DEA’s rules taint the outcome? Seventy-six mostly male veterans between the ages of 24 and 77 completed the Phase 1 trial. View original article.

Clinical Trials 52

Clinical Trials DEA Treatment THC 52

Cannabis Law Report

SEPTEMBER 9, 2021

Medical cannabis is used for the treatment of various chronic conditions, such as Parkinson’s disease, Alzheimer’s disease, arthritis, cancer, depression, anxiety, epilepsy, and other neurological conditions. Thus, a wide application scope has led to an increased product demand for the treatment of various chronic conditions.

Recreational 73

Recreational Hemp THC Legalization 73

Veriheal

APRIL 11, 2022

federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Additionally, numerous other cannabis-based medications have already gained approval or are in the process of being tested in clinical trials. Fortunately, the U.S.

Pharmaceutical 105

Pharmaceutical Research and Development DEA Clinical Trials 105

Cannabis Law Report

DECEMBER 14, 2019

The new law is set to go into effect in 2020 and allows individuals over 18 to possess up to 50 grams of dried flower and cultivate two cannabis plants in their home, with a maximum of four plants per residence. Here is a closer look at the top four stocks on the Australian cannabis index from Canaccord. Give me my free report!

Pharmaceutical 98

Pharmaceutical Patients Clinical Trials Hemp 98

Cannabis Law Report

JANUARY 12, 2022

Management’s decision to end all connections to the cannabis cultivation industry positions Gb Sciences to uplist its stock to a senior exchange and attract institutional investors and strategic partners in the biopharmaceutical drug development sector to accelerate its clinical development progress. 31, 2021.

Research and Development 52

Research and Development Clinical Trials Chronic Pain Therapy 52

CannaMD

AUGUST 8, 2020

This new bill allows broad hemp cultivation. Prior to receiving FDA approval, Epidiolex underwent a number of clinical trials establishing the medical efficacy of CBD. CannaMD ‘s organized all state-approved medical marijuana treatment centers (or dispensaries ) in one easy-to-navigate page: Florida Marijuana Dispensaries.

CBD 105

CBD DEA Research and Development Hemp 105

MMJ Recs

DECEMBER 17, 2023

To qualify for the program, patients must have explored other treatment options unsuccessfully and be under the care of a qualified physician. Image by Roberto Valdivia on Unsplash Texas Medical Marijuana Cultivation Laws The TCUP allows for the cultivation of low-THC cannabis by a limited number of licensed dispensing organizations.

Law 52

Law Clinical Trials Dispensary Programs 52

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. For over three decades, we’ve been working to achieve mass mental health throughout the United States, Canada, and Europe.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

SEPTEMBER 1, 2019

By early 2016, Australia’s federal parliament passed a bill that laid the groundwork for cannabis to be legally cultivated and manufactured for medicinal and scientific purposes here. The clinical trials and the standard of production could lead the world.”. Fitzsimons seized the opportunity.

Clinical Trials 53

Clinical Trials Research and Development Medicine Cultivation 53

Cannabis Law Report

OCTOBER 29, 2019

. “While many Australians may view cannabis use as harmless, almost a quarter of Australia’s drug and alcohol treatment services are being provided to people identifying cannabis as their principle drug of concern, roughly the same number of treatment episodes as for amphetamine use.”

Law 51

Law Clinical Trials Legalization Legislation 51

The Joint Blog

FEBRUARY 18, 2020

The findings suggest that some ADHD patients may consume cannabis as a “substitute treatment” for more conventional medications, authors concluded. METHODS: Participants were adult patients licensed for medical cannabis (MC) treatment who also reported a diagnosis of ADHD by a physician.

Clinical Trials 45

Clinical Trials Terpenes Data Cannabinoids 45

Cannabis Law Report

JUNE 11, 2021

“As a consequence, studies of the structural, chemical, and possibly fortuitous pharmacological properties of these unknown compounds may lead to the development of beneficial pharmacological treatments for a number of disease states.”. Mydecine has also successfully completed multiple acquisitions since its inception.

Research and Development 45

Research and Development Clinical Trials Therapy Pharmaceutical 45

SpeedWeed

MAY 12, 2021

Under the newly announced partnership, Silo Wellness will operate two 5-MeO-DMT retreats in Jamaica, where the company already conducts psilocybin-assisted retreats and mushroom and truffle cultivation workshops. . The series of events includes retreats geared at consumers with a variety of interests and backgrounds.

Clinical Trials 52

Clinical Trials Therapy Cultivation Events 52

Freedom Leaf

JANUARY 10, 2018

“We’re actively working toward developing new genetics to work on efficacy and assist the patients in Israel still operating with our nurse-run clinics in order to better provide the right dosage and strains for the patients who are referred to us by the Ministry of Health,” Stephen Gardner, Tikun Olam’s chief marketing officer, tells Freedom Leaf.

Research and Development 49

Research and Development Clinical Trials Strains Patients 49

Cannabis Law Report

MARCH 3, 2022

This was accomplished via the SVG Bureau of Standards creating a Scientific Research License that allows for the cultivation, processing, import/export of psychedelic compounds for medicinal purposes and scientific research. The eventual trials would target PTSD, addiction, alcoholism, depression, and anxiety. and Europe.

Research and Development 52

Research and Development Medicine Clinical Trials Microdosing 52

Cannabis Law Report

MARCH 16, 2022

The PsyBio team has extensive experience in drug discovery and development based on synthetic biology, metabolic engineering, medicinal chemistry and clinical pharmacology, as well as clinical and regulatory expertise progressing drugs through human studies and governmental protocols.

Research and Development 52

Research and Development Pharmaceutical Clinical Trials Medicine 52

Cannabis Law Report

FEBRUARY 2, 2022

– Flora seeks approval to take their patent-pending, cannabinoid-based product through clinical trials under an EUA from INVIMA (Colombian FDA). Dr. Manalo-Morgan has spent the last 5 years researching cannabis and has specialized in the formulation of cannabinoid products for clinical trials.

Cannabinoids 40

Cannabinoids Clinical Trials Events Cultivation 40

Cannabis Law Report

JULY 4, 2019

The programme aims to investigate mechanisms of action of cannabis-based medicinal products related to several clinical applications including pain and cancer, as well as characterise cannabis-based medicinal products in disease models with particular focus of chronic pain, spasticity and cancer. About EMMAC.

Cannabinoids 40

Cannabinoids Clinical Trials Chronic Pain Medicine 40

Cannabis Law Report

NOVEMBER 7, 2019

Cannatrek’s Seed to Patient business model combines cutting edge cultivation expertise and world class manufacturing practices to deliver high quality medicinal cannabis oil formulations and medicinal strains of dried flowers at a significantly lower cost to patients and retailers.

Medicine 40

Medicine Patients Research and Development Clinical Trials 40

The Cannigma

AUGUST 26, 2021

A major move in the direction of legalization took place in September 2019, when the Australian Capital Territory legalized cannabis possession (up to 50 grams) and the cultivation of up to two cannabis plants. In addition, as of early 2021 , it is legal to purchase CBD oil over the counter in Australia. Costs of medical marijuana.

Legalization 52

Legalization Access Medicine Clinical Trials 52

SpeedWeed

AUGUST 4, 2021

Medical Cannabis Australia, the company she founded, just obtained its cultivation and manufacture licenses from the Office of Drug Control (ODC) in April of this year. This event saw doctors and researchers from all over the world presenting the scientific and clinical studies surrounding the medical benefits of cannabis. .

Chronic Pain 52

Chronic Pain Research and Development Medicine Supply Chain 52

Cannabis Law Report

JUNE 9, 2022

We understand the number of people who will need medical treatment due to this exposure. The bill would expand patients’ access to the necessary treatment for more than 50 conditions, including cancer and post-traumatic stress disorder (PTSD), neurological diseases, and chronic pain of neuropathic origin.

Seed-To-Sale 52

Seed-To-Sale Legalization Cultivation Medicine 52

Cannabis Law Report

DECEMBER 20, 2021

It is also called industrial hemp , plant of the family Cannabaceae cultivated for its bast fibre or its edible seeds 1. Since only three states have started granting licenses for the cultivation of cannabis, it is not clear to whom the application shall be made in other states. Regulation 2.16.

Seed-To-Sale 52

Seed-To-Sale Hemp Food Clinical Trials 52

Miss Marijuana

MARCH 15, 2021

The world of CBD flowers has brought a whole new avenue of treatment to medicine. For outdoor cultivation, this plant can grow up to six feet tall and harvest time occurs around mid-October. By Will Keever. Many of these flowers would not have come into existence if were it not for the creator of Ringo’s Gift. Chronic stress.

Strains 52

Strains Indica Sativa Clinical Trials 52

Cannabis Law Report

OCTOBER 3, 2019

The Australian Capital Territory ( ACT ) voted to legalise the personal possession and cultivation of cannabis. The ACT Legislative Assembly voted to legalise the personal possession and cultivation of cannabis on 25 September 2019. Final Report Reviewing Framework for Medicinal Cannabis Cultivation, Production and Manufacture.

Medicine 40

Medicine Research and Development Cultivation Supply Chain 40

SpeedWeed

MARCH 5, 2021

One, they have been determined by the US Food and Drug Administration to be clinically safe and effective treatments for a specific medical condition. Rescheduling cannabis will not necessarily facilitate clinical research. Two, they are federally classified by DEA and HHS as Schedule II, III, IV or V substances.

Business 52

Business Policy Clinical Trials Research and Development 52

Cannabis Law Report

JANUARY 24, 2022

The CBD segment dominated the market in 2021 due to the growing awareness about the positive effects of CBD for the treatment of various medical conditions, such as chronic pain, cancer & multiple sclerosis. Growing adoption of medical marijuana for treatment of chronic diseases. Illicit cannabis trade due to surplus cultivation.

Legalization 40

Legalization Supply Chain Chronic Pain Recreational 40

Cannabis Law Report

FEBRUARY 3, 2022

The oil segment is accounted to have the largest share in global cannabis treatment market during the forecast period. Growing Adoption of Medical Cannabis for the Treatment of Chronic Compounds. Intensive Energy Consumption and Maintaining Product Consistency for the Cultivation of Cannabis. Impact Factor Analysis. Restraints.

Indica 40

Indica Oil Legalization Clinical Trials 40

Cannabis Law Report

SEPTEMBER 3, 2019

MediPharm Labs Australia has also successfully negotiated multi-year supply agreements with three Australian Office of Drug Control (“ODC”) approved cultivators (including BBS Pharmaceuticals). The laws allow concentrate-based medical cannabis to be prescribed in Australia for the treatment of a variety of specific illnesses.

Pharmaceutical 45

Pharmaceutical Extraction Research and Development Supply Chain 45